Active Stocks

Fri Jun 05 2026 15:45:16

State Bank of India share price
977.75 -0.19%

Eternal share price
256.45 0.85%

ITC share price
280.75 0.16%

Reliance Industries share price
1,291.20 -1.00%

Tata Steel share price
206.80 -1.78%

Business News > Mint Authors > David Wainer

David Wainer

ARTICLES BY DAVID WAINER

Natera builds a personalized blood test to look for cancer recurrence.

The Cancer Test That Wall Street Is Betting On

3 min read . 14 May 2026

Markets outside the U.S. hold huge potential for weight-loss drugs such as Wegovy.

America’s Weight-Loss Drug Boom Is Going Global

3 min read . 07 May 2026

The pharma sector has many stocks that are relatively inexpensive relative to their growth. George Frey/Bloomberg News

Why investors aren’t fleeing to safe-haven stocks

4 min read . 12 Mar 2026

Wegovy weight-loss pills Novo Nordisk

The weight-loss price wars are breaking Big Pharma’s business model

4 min read . 07 Feb 2026

President Trump claimed his 'most favoured nation’ policy would slash US prescription costs. (File Photo: Reuters)

Can Trump and Big Pharma get the world to pay more for drugs?

4 min read . 25 Jan 2026

Eli Lilly now captures a clear majority of new obesity-drug prescriptions. Photo: Reuters

The weight-loss craze is about to mint a trillion-dollar company

3 min read . 18 Nov 2025

US President Donald Trump announced a drug-price deal last week. (Bloomberg)

Obesity drugs are about to go mass-market

4 min read . 11 Nov 2025

Injection pens for Wegovy, the weight-loss treatment from Novo Nordisk. (File Photo: Reuters)

Why Pfizer can still prevail in the obesity fight with Novo Nordisk

3 min read . 02 Nov 2025

The biotech sector’s share prices still look reasonable.

Why biotech’s rally can last this time

3 min read . 13 Oct 2025

Most big drugmakers are already expanding U.S. manufacturing, which should shield them from steep duties. (Bloomberg)

Drug tariffs are a sideshow. Trump’s next move could hit pharma harder.

3 min read . 27 Sept 2025

Novo Nordisk, maker of Ozempic and Wegovy, has a reputation for squandering its lead.. (Photo by Mads Claus Rasmussen / Ritzau Scanpix / AFP) (AFP)

Ozempic’s maker got crushed. The rebound is under way.

3 min read . 21 Sept 2025

Airbnb co-founder and CEO Brian Chesky has said Airbnb should be an everything app for everyday life. Photo: patrick t. fallon/Agence France-Presse/Getty Images

Can Airbnb redefine travel again?

4 min read . 25 Jul 2025

Gilead Sciences in Oceanside, Calif. Photo: Mike Blake/REUTERS

A new shot prevents HIV—and breathes new life into a stagnant biotech

3 min read . 05 Jun 2025

US President Donald Trump. (AP)

Trump’s drug price crackdown, like his trade war, could be more bark than bite

4 min read . 13 May 2025

In the past two weeks, as prescription volumes have remained sluggish, analysts cut first-quarter sales estimates for Wegovy by about 5%. (REUTERS)

Why new Wegovy deals won’t restore Novo Nordisk’s obesity lead

3 min read . 30 Apr 2025

Pfizer is among the drug companies that have managed to pay little in income tax in the U.S.

How Trump’s tariffs could upend pharma’s overseas tax strategy

4 min read . 02 Apr 2025

Though Gilead has struggled for years to find momentum, its stock has climbed 21% in 2025. Photo: Jason Henry for WSJ

Drug stocks are the new safe bet in a shaky market

3 min read . 28 Feb 2025

China’s rise in biotech has been years in the making, but it is now impossible to ignore. (Image: Pixabay)

The drug industry is having its own DeepSeek moment

4 min read . 07 Feb 2025

After analyzing data going back to 2016, one analyst thinks he has identified a seasonal pattern in demand for drugs such as Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy. (REUTERS)

Are weight-loss drugs like gym memberships? The answer is worth billions

3 min read . 29 Jan 2025

Pfizer CEO Albert Bourla said the prior administration was influenced by progressive priorities. (Reuters)

Beaten down under Biden, big pharma hopes for new chapter under Trump

3 min read . 20 Jan 2025